418 related articles for article (PubMed ID: 21151563)
1. Immune protection induced on day 10 following administration of the 2009 A/H1N1 pandemic influenza vaccine.
Sun Y; Bian C; Xu K; Hu W; Wang T; Cui J; Wu H; Ling Z; Ji Y; Lin G; Tian L; Zhou Y; Li B; Hu G; Yu N; An W; Pan R; Zhou P; Leng Q; Huang Z; Ma X; Sun B
PLoS One; 2010 Dec; 5(12):e14270. PubMed ID: 21151563
[TBL] [Abstract][Full Text] [Related]
2. Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.
Bai Y; Shi N; Lu Q; Yang L; Wang Z; Li L; Han H; Zheng D; Luo F; Zhang Z; Ai X
Hum Vaccin Immunother; 2015; 11(7):1648-53. PubMed ID: 26083828
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of pandemic H1N1 antibody among health care workers in Hong Kong following receipt of monovalent 2009 H1N1 influenza vaccine.
Zhou Y; Ng DM; Seto WH; Ip DK; Kwok HK; Ma ES; Ng S; Lau LL; Peiris JS; Cowling BJ
PLoS One; 2011; 6(11):e27169. PubMed ID: 22102878
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan.
Uno S; Kimachi K; Matsuo F; Miyazaki K; Oohama A; Kei J; Nishimura T; Odoh K; Kino Y
Microbiol Immunol; 2012 Dec; 56(12):810-6. PubMed ID: 23009167
[TBL] [Abstract][Full Text] [Related]
5. Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.
Ott U; Sauerbrei A; Lange J; Schäfler A; Walther M; Wolf G; Wutzler P; Zell R; Krumbholz A
Med Microbiol Immunol; 2012 Aug; 201(3):297-302. PubMed ID: 22350187
[TBL] [Abstract][Full Text] [Related]
6. Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees.
Herrera MT; Gonzalez Y; Juárez E; Hernández-Sánchez F; Carranza C; Sarabia C; Guzman-Beltran S; Manjarrez ME; Muñoz-Torrico M; Garcia-Garcia L; Sada E; Torres M
BMC Infect Dis; 2013 Nov; 13():544. PubMed ID: 24238117
[TBL] [Abstract][Full Text] [Related]
7. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
[TBL] [Abstract][Full Text] [Related]
8. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
[TBL] [Abstract][Full Text] [Related]
9. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
[TBL] [Abstract][Full Text] [Related]
10. [Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice].
Huang BY; Wang XP; Wang WL; Hu W; Gao Q; Tan WJ; Ruan L
Bing Du Xue Bao; 2011 May; 27(3):265-73. PubMed ID: 21774253
[TBL] [Abstract][Full Text] [Related]
11. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
[TBL] [Abstract][Full Text] [Related]
12. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H
Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Immune Response of Recombinant H1N1 Hemagglutinin with MF59 Adjuvant in Animal Model as a Novel Alternative to the Influenza Vaccine.
Rashedi N; Taghizadeh M; Mohamadynejad P; Mahdavi M; Jalalirad R
Iran J Allergy Asthma Immunol; 2020 Oct; 19(5):497-508. PubMed ID: 33463117
[TBL] [Abstract][Full Text] [Related]
14. Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults.
Ikematsu H; Nagai H; Kawashima M; Kawakami Y; Tenjinbaru K; Li P; Walravens K; Gillard P; Roman F
Hum Vaccin Immunother; 2012 Feb; 8(2):260-6. PubMed ID: 22426369
[TBL] [Abstract][Full Text] [Related]
15. Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients.
Salles MJ; Sens YA; Malafronte P; Souza JF; Vilas Boas LS; Machado CM
Transpl Infect Dis; 2012 Dec; 14(6):564-74. PubMed ID: 22882692
[TBL] [Abstract][Full Text] [Related]
16. Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.
Strengell M; Ikonen N; Ziegler T; Kantele A; Anttila VJ; Julkunen I
Influenza Other Respir Viruses; 2013 May; 7(3):431-8. PubMed ID: 22913369
[TBL] [Abstract][Full Text] [Related]
17. AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.
Caillet C; Piras F; Bernard MC; de Montfort A; Boudet F; Vogel FR; Hoffenbach A; Moste C; Kusters I
Vaccine; 2010 Apr; 28(18):3076-9. PubMed ID: 20193791
[TBL] [Abstract][Full Text] [Related]
18. Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice.
Shin JH; Park JK; Lee DH; Quan FS; Song CS; Kim YC
PLoS One; 2015; 10(6):e0130684. PubMed ID: 26086590
[TBL] [Abstract][Full Text] [Related]
19. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity.
Rosendahl Huber SK; Hendriks M; Jacobi RHJ; van de Kassteele J; Mandersloot-Oskam JC; van Boxtel RAJ; Wensing AMJ; Rots NY; Luytjes W; van Beek J
Front Immunol; 2018; 9():3103. PubMed ID: 30761157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
